Galapagos NV
GLPG
#4956
Rank
NZ$3.18 B
Marketcap
NZ$47.39
Share price
0.00%
Change (1 day)
-1.34%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): NZ-$0.93

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.70. In 2024 the company made an earnings per share (EPS) of NZ$1.99 a decrease over its 2023 EPS that were of NZ$6.06.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$0.93
2024NZ$1.99-67.16%
2023NZ$6.06-199.64%
2022NZ-$6.0999.03%
2021NZ-$3.06-68.98%
2020NZ-$9.86-298.06%
2019NZ$4.98-554.64%
2018NZ-$1.09-77.18%
2017NZ-$4.80-326.21%
2016NZ$2.12-134.19%
2015NZ-$6.20-371.34%
2014NZ$2.29-445.98%
2013NZ-$0.6632.88%
2012NZ-$0.50-82.07%
2011NZ-$2.77-817.9%
2010NZ$0.3912.73%
2009NZ$0.34-120.79%
2008NZ-$1.65-37.67%
2007NZ-$2.6539.64%
2006NZ-$1.8928.17%
2005NZ-$1.486.25%
2004NZ-$1.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.93-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.17-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$3.51-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.37-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$6.08-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.88-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.64-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ-$1.04 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.34-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel